Counts describe this library, not the strength of evidence.
Cómo interpretar la evidencia
Strength, muscle size and function are related but distinct outcomes. Trials and reviews support progressive resistance exercise, while longevity cohorts cannot establish exact safe-dose limits. More complicated prescriptions do not consistently outperform achievable basics.
Pooling 35 randomized trials with 5,734 participants, combined aerobic and resistance training improved global cognition by a small-to-moderate amount (g = 0.32, 95% CI 0.17-0.46, p < 0.001), with similar effects in older adults (g = 0.33) and clinical populations (g = 0.28). Pooled estimates blend very different programs and groups, and the abstract does not rate study quality or heterogeneity.
International journal of clinical and health psychology : IJCHP
This narrative review explains how fat infiltration and lipid metabolites in skeletal muscle can disrupt muscle structure, energy handling and signalling, and so worsen function and performance. It summarises mechanisms from many studies and has no new data or numerical results, so it cannot say how much any intervention helps.
This narrative review concludes that resistance training and adequate protein intake remain the cornerstone of managing age-related muscle loss, while newer approaches such as gene editing, stem cells and microbiome-directed diets show only early promise. It pools no data and gives no effect sizes, so it cannot say how much any of these strategies helps.
Comparing 42 young adults with 88 older adults (39 non-sarcopenic, 31 pre-sarcopenic, 18 sarcopenic), signs of nerve-muscle junction instability, motor unit loss and nerve damage were found in all older groups, mostly regardless of sarcopenia status. This points to changes that precede diagnosis, but the design is a single cross-sectional comparison in a small sample and cannot show how people progress over time.
Pooling 45 studies with 37,571 people aged 60 or older in China, the prevalence of sarcopenia was 20.7% (95% CI 18.3 to 23.0%), reaching 45.4% at age 80 and above. The pooled studies were cross-sectional, so the listed risk factors are associations, and different diagnostic criteria gave noticeably different rates.
Among 4030 US adults, each 1-unit rise in the triglyceride-glucose (TyG) index was associated with higher odds of sarcopenia (OR 1.31, 95% CI 1.07-1.60) after full adjustment. This is a cross-sectional snapshot, so it cannot show that insulin resistance causes muscle loss.
Among 4395 adults aged 60 and older in China, 24.5% of those with possible sarcopenia returned to non-sarcopenia by the next follow-up, while 6.7% progressed to sarcopenia. Follow-up averaged only 3.29 years across three survey waves, so these are short-term transition rates in one country's survey.
Among 8,238 Chinese adults aged 45 and older, depressive symptoms were associated with higher odds of sarcopenia (OR 1.30, 95% CI 1.03-1.63), and disability in activities of daily living (ADL) accounted for 20.00% of that link. The data come from a survey analysed as an association, so they cannot show that depression leads to muscle loss.
Among 1,725 adults with sarcopenia in NHANES, those in the highest quartile of the monocyte-to-lymphocyte ratio (MLR) had a higher risk of all-cause death (HR = 1.619 [1.290-2.032]) than the lowest quartile. This is an observational link in one US survey, and blood ratios measured once cannot show that inflammation causes the deaths.
Among 5888 older adults in the Rotterdam Study, confirmed sarcopenia (HR 1.93) and sarcopenic obesity with 2 altered body composition components (HR 2.84) were associated with the highest all-cause mortality. This is an observational cohort, so the link does not prove that the muscle or fat changes caused the deaths.
Pooling 20 case-control studies, the overall odds ratio linking sarcopenia and dyslipidemia in older adults was 1.47. The association was strongly region-dependent (OR 4.38 outside China, 0.9 in China), and the abstract gives no confidence intervals, so the strength and consistency of the link are uncertain.
A panel of 19 experts agreed on 3 statements (scores 8.1 to 8.8) and 7 recommendations (7.7 to 8.6) for using flywheel resistance training in sport, all above the 7-9 cut-off for appropriate. This is expert opinion built on 9 review articles, not a new trial, and the abstract does not list the recommendations themselves.
Among 6893 Chinese adults aged 60 and over, 37.2% had sarcopenia, and over 3 years sarcopenia was associated with higher odds of new daily-living disability (ADLs OR 1.58; IADLs OR 1.87). Even possible sarcopenia carried raised odds, but the numbers come from a single national survey and remain associations.
Among 57 people with sarcopenia and 57 without, the sarcopenic group had higher TNF-α (p = 0.007), IL-1β (p < 0.001) and IL-6 (p < 0.001), and these fell after 12 weeks of resistance exercise plus supplements. There was no comparison group for the intervention, so the drop cannot be credited to the program itself.
Pooling 10 studies of 301 patients, handgrip strength did not change significantly about 6 months after bariatric surgery (-0.46 kg; 95% CI -1.76 to 0.84), although lean mass fell by 7.4 kg. The pooled sample is small and follow-up is short, so it cannot say what happens to strength over years.
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
In 7 trials (591 participants) of adults aged 60 or older with sarcopenia, adding whey protein to resistance training gave a small gain in appendicular muscle index (SMD 0.24; 95% CI 0.05 to 0.42) and +2.31 kg in handgrip (95% CI 0.01 to 4.6). The grip difference did not exceed the minimally important clinical difference and the evidence was low to very low quality.
In 295,489 UK Biobank adults, genetically predicted vitamin D below 20 ng/mL was linked to higher sarcopenia risk (odds ratio 1.74 for 10 vs 20 ng/mL; 95% CI 1.17-2.59), with no further benefit above 20 ng/mL. Mendelian randomization reduces confounding but rests on assumptions, and the authors say trials are needed to confirm causality.